Panchatikta Ghrita is a classical medicated ghee, but claims about dramatic responses in psoriatic arthritis, fixed reductions in C-reactive protein, or failure of multiple biologic medicines require patient records and published documentation. No verifiable source was available for the opening case history, so it should not be presented as clinical evidence. The defensible account is more modest: Panchatikta Ghrita has an official Ayurvedic monograph and a classical indication for kushtha, a broad category of skin disorders, while modern evidence for psoriasis and inflammatory arthritis remains limited.

The Ayurvedic Pharmacopoeia of India, Part II, Volume I standardizes Panchatikta Ghrita under AFI Part I, 6:26 and cites Bhaishajya Ratnavali, Kushthadhikara 114-116 as the classical source. The name means “ghee prepared with five bitter drugs,” but the official composition is not limited to five herbs: five plants are used to make the decoction, Triphala is used as the paste, and cow’s ghee is the lipid base. The exact formulation is not attributed by the official monograph to the Charaka Samhita or Ashtanga Hridaya.

The Official Composition

The pharmacopoeial formula uses equal starting quantities of the five decoction drugs. It is therefore misleading to assign each herb a unique proven mechanism, such as “immune regulation,” “liver detoxification,” or “joint protection,” because the finished medicine has not been clinically deconstructed in that way.

  1. Nimba (Azadirachta indica): stem bark. Nimba is one of the five bitter decoction ingredients. Laboratory research exists on neem constituents, but that does not prove that Panchatikta Ghrita treats psoriasis through NF-kB inhibition, antibacterial action, or an “anti-keratolytic” effect.
  2. Patola (Trichosanthes dioica): leaf. The official formula does not describe Patola as a specific liver medicine or connect it with Bhrajaka Pitta through a modern liver-skin mechanism.
  3. Vyaghri or Kantakari (Solanum surattense): whole plant. Its presence does not establish a disease-modifying or cartilage-protective effect in psoriatic or rheumatoid arthritis.
  4. Guduchi (Tinospora cordifolia): stem. Guduchi is often described in contemporary writing as “immunomodulatory,” but human evidence is incomplete, and Guduchi-containing products have also been associated with clinically apparent liver injury.
  5. Vasaka (Adhatoda vasica): root. Vasicine-related pharmacology has been studied mainly in extracts and experimental systems; it cannot be used to claim that the complete ghrita specifically treats hot, weeping, Pitta-type lesions.

The decoction is combined with a paste of Haritaki (Terminalia chebula), Bibhitaka (Terminalia bellirica), and Amalaki (Phyllanthus emblica)—the three fruits known collectively as Triphala—and processed with clarified butter from cow’s milk. Thus, the finished formula contains eight botanical ingredients, not five or seven.

What the Classical and Official Sources Actually Indicate

The API lists dushtavrana (a difficult or non-healing ulcer), kushtha (skin diseases), disorders described in relation to aggravated Vata, Pitta, or Kapha, krimi, arsha, and kasa among its therapeutic uses. These are official Ayurvedic indications, not proof of efficacy for every modern diagnosis that appears superficially similar. Psoriasis may be discussed under different kushtha patterns by practitioners, but “psoriasis equals Kitibha” or “psoriatic arthritis equals Kushtha with Sandhigata Vata” is not a universally exact diagnostic conversion.

Classical descriptions of tikta rasa associate bitter taste with light, drying, and Kapha-Pitta-reducing actions and with use in itching and skin disorders; they also warn that excessive bitter intake can aggravate Vata and deplete tissues. Panchatikta Ghrita combines bitter herbs with ghee, so its use is assessed according to the patient’s digestion, strength, disease stage, bowel pattern, and overall dosha-dhatu presentation rather than by disease name alone.

Clinical Evidence: What Is Known and What Is Not

The clinical literature is too small and methodologically weak to support claims that Panchatikta Ghrita has “two randomized trials” proving benefit for psoriasis, or that it reliably treats eczema, acne, rheumatoid arthritis, or psoriatic arthritis. The following distinction is more accurate:

Use or condition Verified source Evidence assessment
Kushtha and other listed classical uses Ayurvedic Pharmacopoeia of India monograph Official traditional indication; not equivalent to modern proof of clinical efficacy
Psoriasis A 2012 uncontrolled study of 21 patients used 60 mL rectal matra basti daily for three weeks; a 2013 study placed 30 patients into three groups of 10 and used oral ghrita, leech therapy, or both Preliminary, small, non-blinded studies with important design limitations; neither establishes effectiveness against standard dermatologic treatment
Psoriasis trial often cited from 2019 CCRAS multicentre paper It is a study protocol proposing 120 participants, not a published outcome report
Osteopenia Randomized open-label controlled study of 80 adults; 65 completed 12 months Adjunctive Panchatikta Ghrita with calcium and vitamin D improved some bone biomarkers and BMD measures, but the authors called for larger confirmation; this is not evidence for arthritis
Psoriatic arthritis, rheumatoid arthritis, acne, eczema, or chronic infection No robust condition-specific controlled evidence identified for the ghrita alone Effectiveness and appropriate dosing are not established

How the Medicated Ghee Is Prepared

The pharmacopoeial process is a pharmaceutical extraction and concentration method, not proof that the medicine “carries active compounds into lipid-soluble tissue layers.” The five herbs are coarsely powdered, boiled in water, and reduced to one quarter to make a decoction. Triphala is finely powdered and made into a paste. Murchhita ghee is heated gently, the paste and decoction are added in stages, and the mixture is cooked with stirring until moisture is removed and the classical madhyama paka signs appear. The hot ghrita is then filtered and protected from light and moisture.

This method exposes the ingredients to both an aqueous phase and a lipid phase, which may extract a wider range of constituents than water alone. However, no human pharmacokinetic study located for Panchatikta Ghrita demonstrates superior absorption of nimbin, nimbidin, tinosporin, vasicine, or Solanum alkaloids, and no study proves preferential delivery to Rasa, Rakta, bone, joints, skin, or the “gut-liver axis.” Those statements should remain traditional interpretations or research hypotheses, not established mechanisms.

Dose and Administration

The official API dose is 12 g daily in divided doses, with warm milk or warm water as anupana. This is the clearest standardized dose available for the pharmacopoeial product. It does not support a universal 10-20 g daily range, a mandatory 90-day course, or an automatic escalation from 5 g to 20 g.

Snehapana used before Panchakarma is a separate, physician-supervised procedure in which the dose and duration are individualized and signs of proper, inadequate, or excessive oleation are monitored. A maintenance prescription and a purification-level fat-drinking protocol should not be conflated. Taking ghrita on an empty stomach is also not a universal rule for every patient; timing depends on the therapeutic purpose and the prescriber’s assessment.

Compatibility with Conventional Treatment

There are no adequate interaction studies showing that Panchatikta Ghrita can safely accompany “most” conventional medicines. It should not be used as a bridge for tapering methotrexate, corticosteroids, biologics, anticoagulants, or other immunosuppressive treatment unless the prescribing specialists are coordinating the plan. A fall in CRP or improvement in plaques does not by itself justify reducing medication.

Guduchi-containing products have been linked in published reports to acute hepatitis, sometimes with autoimmune features, although the risk of this exact standardized ghrita has not been quantified. People who are pregnant or breastfeeding, or who have liver disease, pancreatitis, gallbladder disease, fat-malabsorption disorders, unexplained abnormal liver tests, or medically prescribed fat restrictions, should obtain individualized medical advice before use. Stop the product and seek medical care for jaundice, dark urine, severe nausea, persistent abdominal pain, rash, facial swelling, or breathing difficulty.

For broader educational context, see our guides to Neem and skin care and Ayurvedic approaches to joint discomfort. These should not replace dermatology or rheumatology care.

Quality and Safety

Choose a licensed manufacturer whose label matches the intended classical reference and whose batch testing covers identity, microbial limits, aflatoxins, pesticide residues, and permitted heavy-metal limits. The API monograph specifies physicochemical and quality parameters, but a classical name on a jar does not guarantee that every commercial product uses the same plant parts or proportions.

Panchatikta Ghrita is not a home kitchen remedy. The suggested practice of steeping fresh neem leaves in ghee for 20 minutes is neither the official Panchatikta Ghrita process nor a validated tolerance test, and fresh-leaf preparations can vary greatly in identity, moisture, strength, and contamination. This article is general information, not medical advice. Consult a qualified Ayurvedic physician and the relevant dermatologist, rheumatologist, or healthcare provider before use.

One Actionable Step

Before taking Panchatikta Ghrita, photograph the full product label and batch number, list every prescription medicine and supplement you use, and ask both clinicians to confirm three points: the exact formula, the reason for prescribing it, and the planned dose and monitoring. Do not stop or taper conventional treatment and do not prepare a substitute at home.

Verified References

References

  1. Natural Ingredient Resource Center
  2. Charaka Samhita — Atreyabhadrakapyiya Adhyaya
  3. Ijrap (ijrap.net)
  4. Wisdomlib — classical text
  5. Jaypeedigital (jaypeedigital.com)
  6. Assessing the Effectiveness of
    Panchatikta Ghrita
    , a Classical Ayurvedic Formulation as Add-on Therapy to Vitamin D
    3
    and Calcium Supplements in Patients with Osteopenia: A Randomized, Open-Labeled, Comparative, Controlled Clinical Study (2019)
  7. NCBI
  8. Tinospora Cordifolia (Giloy)-Induced Liver Injury During the COVID-19 Pandemic-Multicenter Nationwide Study From India (2022), PubMed